Animal drugs, feeds, and related products: Fort Dodge Animal Health,

[Federal Register: October 10, 2002 (Volume 67, Number 197)]

[Rules and Regulations]

[Page 63054-63055]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr10oc02-3]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 510, 520, 522, and 558

New Animal Drugs; Change of Sponsor

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for 15 approved new animal drug applications (NADAs) from Cyanamid Agricultural de Puerto Rico, Inc., to Fort Dodge Animal Health.

DATES: This rule is effective October 10, 2002.

FOR FURTHER INFORMATION CONTACT: Lonnie W. Luther, Center for Veterinary Medicine (HFV-104), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-827-8549, e-mail: lluther@cvm.fda.gov.

SUPPLEMENTARY INFORMATION: Cyanamid Agricultural de Puerto Rico, Inc., P.O.

[[Page 63055]]

Box 243, Manati, PR 00701, has informed FDA that it has transferred ownership of, and all rights and interest in, the following 15 approved NADAs to Fort Dodge Animal Health, A Division of American Cyanamid Co., P.O. Box 1339, Fort Dodge, IA 50501:

NADA [chyph]Number

Trade Name

039-356................. RIPERCOL L Bolus; TRAMISOL Cattle Wormer Bolus 039-357................. RIPERCOL L Soluble Drench Powder 042-740................. RIPERCOL L; TRAMISOL Soluble Drench Powder for Sheep 042-837................. RIPERCOL L Wormer Oblets; TRAMISOL Sheep Wormer Oblets 044-015................. TRAMISOL Type A Medicated [chyph]Article 045-455................. TRAMISOL Type A Medicated [chyph]Article 045-513................. RIPERCOL L 049-553................. RIPERCOL L 092-237................. RIPERCOL L-Piperazine [chyph]Soluble 093-688................. RIPERCOL L-Piperazine 101-079................. TRAMISOL 10% Pig Wormer; TRAMISOL Hog Wormer 102-437................. TRAMISOL Injectable Solution 104-184................. STYQUIN 107-085................. TRAMISOL 126-237................. TRAMISOL Gel

Accordingly, the agency is amending the regulations in 21 CFR 520.1242a, 520.1242b, 520.1242c, 520.1242e, 520.1242f, 522.234, 522.1244, and 558.315 to reflect the transfer of ownership and to reflect current format.

Following this change of sponsorship, Cyanamid Agricultural de Puerto Rico, Inc., is no longer the sponsor of any approved application. Accordingly, 21 CFR 510.600(c) is being amended to remove the entries for Cyanamid Agricultural de Puerto Rico, Inc.

This rule does not meet the definition of ``rule'' in 5 U.S.C. 804(3)(A) because it is a rule of ``particular applicability.'' Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

List of Subjects

21 CFR Part 510

Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.

21 CFR Parts 520 and 522

Animal drugs.

21 CFR Part 558

Animal drugs, Animal feeds.

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, and 558 are amended as follows:

PART 510--NEW ANIMAL DRUGS

  1. The authority citation for 21 CFR part 510 continues to read as follows:

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

    Sec. 510.600 [Amended]

  2. Section 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications is amended in the table in paragraph (c)(1) by removing the entry for ``Cyanamid Agricultural de Puerto Rico, Inc.'' and in the table in paragraph (c)(2) by removing the entry for ``043781''.

    PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS

  3. The authority citation for 21 CFR part 520 continues to read as follows:

    Authority: 21 U.S.C. 360b.

    Sec. 520.1242a [Amended]

  4. Section 520.1242a Levamisole hydrochloride drench and drinking water is amended in paragraph (b)(1) by removing ``043781'' and by adding in its place ``No. 053501''.

    Sec. 520.1242b [Amended]

  5. Section 520.1242b Levamisole hydrochloride tablet or oblet (bolus) is amended in paragraph (c) by removing ``043781'' and by adding in its place ``053501''.

    Sec. 520.1242c [Amended]

  6. Section 520.1242c Levamisole hydrochloride and piperazine dihydrochloride is amended in paragraph (b) by removing ``043781'' and by adding in its place ``053501''.

    Sec. 520.1242e [Amended]

  7. Section 520.1242e Levamisole hydrochloride effervescent tablets is amended in paragraph (b) by removing ``043781'' and by adding in its place ``053501''.

    Sec. 520.1242f [Amended]

  8. Section 520.1242f Levamisole hydrochloride gel is amended in paragraph (b) by removing ``043781'' and by adding in its place ``053501''.

    PART 522--IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

  9. The authority citation for 21 CFR part 522 continues to read as follows:

    Authority: 21 U.S.C. 360b.

    Sec. 522.234 [Amended]

  10. Section 522.234 Butamisole hydrochloride is amended in paragraph (b) by removing ``043781'' and by adding in its place ``053501''.

    Sec. 522.1244 [Amended]

  11. Section 522.1244 Levamisole phosphate injection is amended in paragraph (b) by removing ``043781'' and by adding in its place ``053501''.

    PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

  12. The authority citation for 21 CFR part 558 continues to read as follows:

    Authority: 21 U.S.C. 360b, 371.

    Sec. 558.315 [Amended]

  13. Section 558.315 Levamisole hydrochloride (equivalent) is amended in paragraph (a) by removing ``043781'' and by adding in its place ``No. 053501''.

    Dated: September 26, 2002. Andrew J. Beaulieu, Acting Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

    [FR Doc. 02-25880Filed10-9-02; 8:45 am]

    BILLING CODE 4160-01-S

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT